Phase 3Completed

The fixed-dose combination of fenofibrate with atorvastatin effectively reduces Non-HDL Cholesterol and is superior to atorvastatin or fenofibrate alone

Efficacy and safety of a fixed-dose combination of atorvastatin and fenofibrate versus atorvastatin and fenofibrate monotherapies on non-HDL cholesterol in Mexican adults with mixed dyslipidemia: a randomized clinical trial

Sponsor
Laboratorios Senosiain S.A. de C.V. (Industry)
Enrollment
348 enrolled
Conditions
Reduction of cardiovascular risk in adult patients with mixed dyslipidemia
Interventions
Atorvastatin; fenofibrate
Ages
adults, older adults
Registry
ISRCTN14937154

Full record on ISRCTN

Primary outcomes

  • Non-HDL cholesterol
  • LDL Cholesterol
  • Serum tryglicerides

History

  1. Registered

  2. Study completion

  3. Primary completion

  4. Started